×
Close
註冊
登入
主页
医学图书S馆
医学图书D馆
活动
Upcoming Events
Past Events
用户工具
用户指南
语言
English
中文/ Chinese
French
Português
Español
Arabic
Russian
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
分类
Oncology
51594
Global Medical University
5020
Allergy
1783
Anatomy & Morphology
1527
Andrology
414
Anesthesia & Intensive Care
1214
Anesthesiology
5442
Audiology & Speech-Language Pathology
332
Behavioral Sciences
100
Biochemical Research Methods
6818
Biochemistry & Molecular Biology
29335
Biodiversity Conservation
288
Biology
8218
Biophysics
8099
Biotechnology & Applied Microbiology
8197
Cardiac & Cardiovascular Systems
30752
Cardiovascular & Respiratory Systems
1391
Cell & Tissue Engineering
654
Cell Biology
10825
Chemistry, Analytical
4216
Chemistry, Applied
11003
Chemistry, Medicinal
8487
Chemistry, Multidisciplinary
18503
Clinical Immunology & Infectious Disease
442
Clinical Medicine
8751
Clinical Neurology
16238
Clinical Psychology & Psychiatry
1298
Critical Care Medicine
3153
Dentistry, Oral Surgery & Medicine
12959
Dermatology
7601
Developmental Biology
6915
Ecology
645
Education, Scientific Disciplines
1886
Emergency Medicine
3981
Endocrinology, Metabolism & Nutrition
23582
Engineering, Biomedical
3586
Entomology
425
Environmental Medicine & Public Health
4623
Evolutionary Biology
254
Gastroenterology & Hepatology
11883
General & Internal Medicine
6948
Genetics & Heredity
14711
Geriatrics & Gerontology
5022
Gerontology
338
Health Care Sciences & Services
15636
Health Policy & Services
594
Hematology
5456
Immunology
24666
Infectious Diseases
13671
Integrative & Complementary Medicine
2758
Medical Ethics
1146
Medical Informatics
2117
Medical Laboratory Technology
433
Medicine, General & Internal
44233
Medicine, Legal
493
Medicine, Research & Experimental
17436
Microbiology
22778
Mycology
0
Nanoscience & Nanotechnology
5039
Neuroimaging
1293
Neurology
4396
Neurosciences
38942
Nursing
9355
Nutrition & Dietetics
7802
Obstetrics & Gynecology
8102
Ophthalmology
9493
Optics
4025
Orthopedics
11367
Orthopedics, Rehabilitation & Sports Medicine
1729
Otolaryngology
1505
Otorhinolaryngology
4791
Parasitology
1040
Pathology
4888
Pediatrics
21065
Peripheral Vascular Disease
4693
Pharmacology & Pharmacy
33972
Pharmacology/Toxicology
12027
Physiology
8875
Polymer Science
539
Primary Health Care
795
Psychiatry
18891
Psychology
5053
Psychology, Applied
92
Psychology, Biological
335
Psychology, Clinical
785
Psychology, Developmental
222
Psychology, Educational
149
Psychology, Experimental
122
Psychology, Mathematical
0
Psychology, Multidisciplinary
1590
Psychology, Psychoanalysis
41
Psychology, Social
114
Public Health & Health Care Science
2227
Public, Environmental & Occupational Health
26926
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12032
Radiology, Nuclear Medicine & Medical Imaging
7772
Rehabilitation
2967
Remote Sensing
0
Reproductive Biology
2745
Reproductive Medicine
1131
Research/Laboratory Medicine & Medical Technology
3872
Respiratory System
7101
Rheumatology
5751
Social Sciences, Biomedical
1176
Substance Abuse
2676
Surgery
33275
Toxicology
4241
Transplantation
927
Tropical Medicine
314
Urology & Nephrology
12745
Veterinary Sciences
35
Virology
2383
Zoology
0
渠道
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
103
Pathology Society Understanding disease
52
Asian Journal of Oncology
57
Medrxiv - Oncology
833
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
237
BONE MARROW TRANSPLANTATION
758
BREAST CANCER RESEARCH
284
BREAST CANCER RESEARCH AND TREATMENT
715
BRITISH JOURNAL OF CANCER
987
CA-A CANCER JOURNAL FOR CLINICIANS
24
CANCER
432
CANCER AND METASTASIS REVIEWS
195
CANCER CELL INTERNATIONAL
901
CANCER DISCOVERY
176
CANCER MEDICINE
476
CANCER PREVENTION RESEARCH
70
CANCER RESEARCH
297
CANCER RESEARCH AND TREATMENT
20
CANCER SCIENCE
256
CANCERS
4437
CLINICAL CANCER RESEARCH
312
CLINICAL EPIGENETICS
446
CURRENT ONCOLOGY REPORTS
395
CURRENT OPINION IN ONCOLOGY
227
CURRENT TREATMENT OPTIONS IN ONCOLOGY
289
EXPERIMENTAL CELL RESEARCH
774
HEMATOLOGICAL ONCOLOGY
172
INTERNATIONAL JOURNAL OF CANCER
292
JOURNAL FOR IMMUNOTHERAPY OF CANCER
1334
JOURNAL OF CANCER
20
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
990
JOURNAL OF CLINICAL ONCOLOGY
1011
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
783
JOURNAL OF HEMATOLOGY & ONCOLOGY
376
JOURNAL OF NEURO-ONCOLOGY
734
JOURNAL OF PATHOLOGY
39
JOURNAL OF SURGICAL ONCOLOGY
253
LEUKEMIA
756
LIVER CANCER
145
MEDICAL ONCOLOGY
344
MOLECULAR CANCER
467
MOLECULAR CANCER THERAPEUTICS
157
MOLECULAR ONCOLOGY
201
NATURE REVIEWS CANCER
293
NATURE REVIEWS CLINICAL ONCOLOGY
323
NEOPLASIA
259
ONCOGENE
974
ONCOGENESIS
182
ONCOLOGIST
223
ONCOLOGY-NEW YORK
75
ONCOTARGETS AND THERAPY
572
PSYCHO-ONCOLOGY
175
SURGICAL ONCOLOGY-OXFORD
310
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
166
BMC CANCER
1887
CANCER EPIDEMIOLOGY
406
CANCER GENETICS
31
CANCER MANAGEMENT AND RESEARCH
956
CURRENT ONCOLOGY
816
FRONTIERS IN ONCOLOGY
10107
FUTURE ONCOLOGY
131
GENES CHROMOSOMES & CANCER
58
HEREDITARY CANCER IN CLINICAL PRACTICE
88
INFECTIOUS AGENTS AND CANCER
176
INTEGRATIVE CANCER THERAPIES
69
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
630
JOURNAL OF BUON
11
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
294
JOURNAL OF HEPATOCELLULAR CARCINOMA
368
ONCOLOGY
93
ONCOLOGY RESEARCH AND TREATMENT
164
PEDIATRIC BLOOD & CANCER
403
SEMINARS IN ONCOLOGY NURSING
242
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
204
THORACIC CANCER
271
TUMORI J
67
INDIAN JOURNAL OF CANCER
122
JOURNAL OF ONCOLOGY PRACTICE
436
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
910
RADIATION ONCOLOGY
514
WORLD CANCER RESEARCH JOURNAL
129
SOUTH ASIAN JOURNAL OF CANCER
288
BREAST CANCER-BASIC AND CLINICAL RESEARCH
23
CANCER REPORTS
184
CASE REPORTS IN ONCOLOGY
358
CLINICAL CANCER INVESTIGATION JOURNAL
10
CURRENT BREAST CANCER REPORTS
99
CURRENT CANCER THERAPY REVIEWS
23
CURRENT COLORECTAL CANCER REPORTS
29
INDIAN JOURNAL OF SURGICAL ONCOLOGY
533
INTERNATIONAL CANCER CONFERENCE JOURNAL
176
INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY
15
JMIR CANCER
191
JOURNAL OF GASTROINTESTINAL CANCER
375
JOURNAL OF KIDNEY CANCER AND VHL
82
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE
126
RARE TUMORS
23
REHABILITATION ONCOLOGY
104
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY
229
MIDDLE EAST JOURNAL OF CANCER
155
NATURE CANCER
414
ONCOLOGY AND THERAPY
110
ONCOLOGY REVIEWS
17
ONKOLOGIJA
39
HORMONES & CANCER / DISCOVER ONCOLOGY
167
FAMILIAL CANCER
143
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
483
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
78
MEDICAL ONCOLOGY
359
PATHOLOGY & ONCOLOGY RESEARCH
21
PSYCHO-ONCOLOGIE
20
STRAHLENTHERAPIE UND ONKOLOGIE
390
SUPPORTIVE CARE IN CANCER
1147
TARGETED ONCOLOGY
222
SCI时时刷
search
全部
推荐
+
Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion
Cutaneous squamous cell carcinoma (CSCC) is the second most common skin malignancy in white-skinned populations. Only a mi...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines
Background:Evidence to date supports continued human epidermal growth factor receptor 2 (HER2) suppression beyond progress...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Predicting treatment outcomes using 18F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy
Background:Predictive markers for treatment response and survival outcome have not been identified in patients with advanc...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial
Background:FOLFIRI [irinotecan, folinic acid (CF), and fluorouracil] is considered a standard second-line chemotherapy reg...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study
Background:Perioperative chemotherapy is a recommended treatment approach for localised oesophago-gastric junction adenoca...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis
Background:Primary breast cancer (BC) has shown a higher immune infiltration than the metastatic disease, justifying the o...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy
Background:A reliable model is needed to estimate the risk of postoperative recurrence and the benefits of postoperative r...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Retraction notice: Downregulation of long noncoding RNA LINC01419 inhibits cell migration, invasion, and tumor growth and promotes autophagy via inactivation of the PI3K/Akt1/mTOR pathway in gastric cancer.
Access to society journal content varies across our titles. If you have access to a journal via a society or association ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)
Background:Standard intravenous (IV) paclitaxel is associated with hypersensitivity/toxicity. Alternative IV formulations ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
Due to occupational asbestosis exposure, the incidence of malignant pleural mesothelioma (MPM) has continuously increased ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial
Purpose:To evaluate efficacy and safety of veliparib combined with carboplatin/paclitaxel in patients with advanced human ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
Access to society journal content varies across our titles. If you have access to a journal via a society or association ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Correction notice to “Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model”
Chiao-Fang TengGraduate Institute of Biomedical Sciences, China Medical University, No.91, Hsueh-Shih Rd., Northern Dist....
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT)
Introduction:For epidermal growth factor receptor mutation-positive (EGFRm) non-small-cell lung cancer (NSCLC), EGFR-tyros...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
A novel event-free survival endpoint in locally advanced pancreatic cancer
The treatment paradigm for locally advanced pancreatic cancer (LAPC) is evolving rapidly. The development of neoadjuvant t...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects
Drug approval for early-stage breast cancer (EBC) has been historically granted in the context of registration trials base...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting
Background:The evolution of therapeutic landscape of human epidermal growth factor receptor-2 (HER2)-positive breast cance...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Novel emerging biomarkers to immunotherapy in kidney cancer
The treatment of metastatic renal cell carcinoma has significantly evolved in recent years, particularly with the advent o...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer
Background:Ovarian cancer (OvCa) constitutes a rare and highly aggressive malignancy and is one of the most lethal of all ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
Background:Liposomal irinotecan (nal-IRI) plus 5-fluorouracil and leucovorin (5-FU/LV) is currently the standard second-li...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer
Purpose:This phase III study compared the efficacy and safety of proposed biosimilar MYL-1402O with reference bevacizumab ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
Background:Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial
Background:The aim of this study was to evaluate the efficacy and safety of gemcitabine plus nab-paclitaxel (GnP) as secon...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Comprehensive analysis of prognostic value of lymph node classifications in esophageal squamous cell carcinoma: a large real-world multicenter study
Background:We aim to assess the prognostic ability of three common lymph node–based staging algorithms, namely, the number...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Background:Cancer patients are at higher risk of COVID-19 complications and mortality than the rest of the population. Bre...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model
Background:Minibeam radiation therapy is an experimental radiation therapy utilizing an array of parallel submillimeter pl...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases
Background:The objective of this study was to construct a risk classification system integrating cell-free Epstein-Barr vi...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mutational profile for the differential diagnosis with primary mucinous ovarian carcinoma
Background:Ovarian metastases (OM) of pancreatic adenocarcinoma (PA) (OM-PA) can mimic primary ovarian mucinous carcinoma ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
Prostate-specific membrane antigen (PSMA) is highly expressed on the membrane of most prostate cancer cells and to a lesse...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
A case of advanced adenocarcinoma genetically confirmed with EGFR/BRAF co-mutation in both primary and metastatic lesions
Driver mutations in lung cancer have been generally considered mutually exclusive; however, multiple gene screenings have ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin